RCKT logo

Rocket Pharmaceuticals (RCKT) Cash From Financing

Annual CFF

$185.74 M
-$22.66 M-10.87%

December 1, 2024


Summary


Performance

RCKT Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRCKTcash flowmetrics:

Quarterly CFF

$182.85 M
+$182.67 M+103791.48%

December 1, 2024


Summary


Performance

RCKT Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRCKTcash flowmetrics:

TTM CFF

$185.74 M
+$182.46 M+5561.05%

December 1, 2024


Summary


Performance

RCKT TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRCKTcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

RCKT Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.9%0.0%0.0%
3 y3 years+392.9%-3.5%-41.3%
5 y5 years+4.5%-3.5%-41.3%

RCKT Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.9%+392.9%-3.5%>+9999.0%-41.3%+5561.1%
5 y5-year-34.4%+392.9%-35.3%>+9999.0%-41.8%+5561.1%
alltimeall time-34.4%>+9999.0%-35.3%+820.3%-41.8%>+9999.0%

Rocket Pharmaceuticals Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
$185.74 M(-10.9%)
$182.85 M(>+9900.0%)
$185.74 M(+5561.0%)
Sep 2024
-
$176.00 K(-88.5%)
$3.28 M(-98.3%)
Jun 2024
-
$1.53 M(+29.2%)
$192.59 M(+0.7%)
Mar 2024
-
$1.18 M(+202.8%)
$191.24 M(-8.2%)
Dec 2023
$208.40 M(+34.2%)
$391.00 K(-99.8%)
$208.40 M(-34.1%)
Sep 2023
-
$189.49 M(>+9900.0%)
$316.45 M(+102.2%)
Jun 2023
-
$182.00 K(-99.0%)
$156.49 M(-9.8%)
Mar 2023
-
$18.34 M(-83.1%)
$173.56 M(+11.8%)
Dec 2022
$155.29 M(+312.1%)
$108.44 M(+267.3%)
$155.29 M(+223.6%)
Sep 2022
-
$29.53 M(+71.2%)
$47.98 M(+6.4%)
Jun 2022
-
$17.25 M(>+9900.0%)
$45.10 M(+55.7%)
Mar 2022
-
$76.00 K(-93.3%)
$28.96 M(-23.1%)
Dec 2021
$37.68 M(-86.7%)
$1.14 M(-95.7%)
$37.68 M(-88.2%)
Sep 2021
-
$26.64 M(+2289.1%)
$318.99 M(+8.9%)
Jun 2021
-
$1.11 M(-87.3%)
$292.86 M(+0.3%)
Mar 2021
-
$8.79 M(-96.9%)
$291.90 M(+3.1%)
Dec 2020
$282.99 M(+59.2%)
$282.44 M(>+9900.0%)
$282.99 M(+204.4%)
Sep 2020
-
$512.00 K(+239.1%)
$92.95 M(+0.5%)
Jun 2020
-
$151.00 K(-229.1%)
$92.47 M(-48.0%)
Mar 2020
-
-$117.00 K(-100.1%)
$177.67 M(-0.1%)
Dec 2019
$177.79 M
$92.41 M(>+9900.0%)
$177.79 M(+11.0%)
Sep 2019
-
$31.00 K(-100.0%)
$160.22 M(-0.1%)
Jun 2019
-
$85.35 M(>+9900.0%)
$160.34 M(+113.8%)
DateAnnualQuarterlyTTM
Mar 2019
-
$0.00(-100.0%)
$74.98 M(-51.2%)
Dec 2018
$153.50 M(>+9900.0%)
$74.83 M(>+9900.0%)
$153.50 M(+188.1%)
Sep 2018
-
$149.00 K(>+9900.0%)
$53.28 M(+0.4%)
Jun 2018
-
$0.00(-100.0%)
$53.09 M(-6.8%)
Mar 2018
-
$78.52 M(-409.3%)
$56.99 M(>+9900.0%)
Dec 2017
$19.00 K(-100.0%)
-$25.39 M(>+9900.0%)
$19.00 K(-99.9%)
Sep 2017
-
-$39.00 K(-101.0%)
$25.62 M(-65.5%)
Jun 2017
-
$3.90 M(-81.9%)
$74.34 M(-0.4%)
Mar 2017
-
$21.55 M(>+9900.0%)
$74.63 M(+40.6%)
Dec 2016
$53.08 M(-57.7%)
$213.00 K(-99.6%)
$53.08 M(+0.3%)
Sep 2016
-
$48.69 M(+1064.2%)
$52.94 M(-32.3%)
Jun 2016
-
$4.18 M(>+9900.0%)
$78.22 M(+5.7%)
Mar 2016
-
$0.00(-100.0%)
$74.00 M(-41.0%)
Dec 2015
$125.52 M(>+9900.0%)
$73.00 K(-99.9%)
$125.52 M(-0.9%)
Sep 2015
-
$73.97 M(<-9900.0%)
$126.70 M(+143.5%)
Jun 2015
-
-$40.00 K(-100.1%)
$52.04 M(-0.1%)
Mar 2015
-
$51.51 M(+4004.7%)
$52.08 M(+9069.4%)
Dec 2014
$568.00 K(-96.8%)
$1.25 M(-282.7%)
$568.00 K(-182.7%)
Sep 2014
-
-$687.00 K(<-9900.0%)
-$687.00 K(<-9900.0%)
Jun 2014
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2014
-
$0.00
$0.00
Dec 2013
$17.88 M(+615.0%)
-
-
Dec 2012
$2.50 M
-
-

FAQ

  • What is Rocket Pharmaceuticals annual cash flow from financing activities?
  • What is the all time high annual CFF for Rocket Pharmaceuticals?
  • What is Rocket Pharmaceuticals annual CFF year-on-year change?
  • What is Rocket Pharmaceuticals quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Rocket Pharmaceuticals?
  • What is Rocket Pharmaceuticals quarterly CFF year-on-year change?
  • What is Rocket Pharmaceuticals TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Rocket Pharmaceuticals?
  • What is Rocket Pharmaceuticals TTM CFF year-on-year change?

What is Rocket Pharmaceuticals annual cash flow from financing activities?

The current annual CFF of RCKT is $185.74 M

What is the all time high annual CFF for Rocket Pharmaceuticals?

Rocket Pharmaceuticals all-time high annual cash flow from financing activities is $282.99 M

What is Rocket Pharmaceuticals annual CFF year-on-year change?

Over the past year, RCKT annual cash flow from financing activities has changed by -$22.66 M (-10.87%)

What is Rocket Pharmaceuticals quarterly cash flow from financing activities?

The current quarterly CFF of RCKT is $182.85 M

What is the all time high quarterly CFF for Rocket Pharmaceuticals?

Rocket Pharmaceuticals all-time high quarterly cash flow from financing activities is $282.44 M

What is Rocket Pharmaceuticals quarterly CFF year-on-year change?

Over the past year, RCKT quarterly cash flow from financing activities has changed by $0.00 (0.00%)

What is Rocket Pharmaceuticals TTM cash flow from financing activities?

The current TTM CFF of RCKT is $185.74 M

What is the all time high TTM CFF for Rocket Pharmaceuticals?

Rocket Pharmaceuticals all-time high TTM cash flow from financing activities is $318.99 M

What is Rocket Pharmaceuticals TTM CFF year-on-year change?

Over the past year, RCKT TTM cash flow from financing activities has changed by $0.00 (0.00%)